Products

What will AGI do for Bekanamycin?

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H37N5O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 15JT14C3GI chemically known as (1r,2s,3s,4r,6s)-4,6-diamino-3-((3-amino-3-deoxy-.alpha.-d-glucopyranosyl)oxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranoside but generally known as bekanamycin, which bears US NIH Compound Identifier 816. European Medicines Agency schedules Bekanamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05684MIG. The term BEKANAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , no. 10 1971, list 11. ). Most nations schedule bekanamycin under HS 29419000 and SITC 54139. As of Q4 2014, BEKANAMYCIN remains the US FDA Preferred Term for this commodity. Bekanamycin bears US NLM identifiers UMLS ID C0053076 and NCI Concept Code C65248. SMILES: C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N.